[1]Mao QC, Unadkat JD. Role of the breast cancer resistance protein (ABCG2) in drug transport[J]. The AAPS Journal, 2005, 7(1): E118133.
[2]李卫红,青雪梅,华茜,等.大鼠脑微血管内皮细胞条件培养液对皮层神经元活性的影响以及通络救脑注射液的干预作用[J].中华中医药杂志,2006,21(6):334337.
[3]Narang VS, Fraga C, Kumar N, et al. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat bloodbrain barrier[J]. Am J Physiol Cell Physiol, 2008, 295(2): C440C450.
[4]Sukowati CHC, Rosso N, Pascut D, et al. Gene and functional upregulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma[J]. BMC Gastroenterology, 2012, 12: 160.
[5]Liu JYW, Thom M, Catarino CB, et al. Neuropathology of the bloodbrain barrier and pharmacoresistance in human epilepsy[J]. Brain, 2012, 135(10): 31153133.
[6]Englund G, Jacobson A, Rorsman F, et al. Efflux transporters in ulcerative colitis: decreased expression of BCRP(ABCG2) and Pgp(ABCB1)[J]. Inflamm Bowel Dis, 2007, 13(3): 291297.
[7]Nakanishi H, Yonezawa A, Matsubara K, et al. Impact of Pglycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models[J]. European Journal of Pharmacology, 2013, 710(13): 2028.
[8]赵康峰,王翀,孔建,等.不同血脑屏障模型的建立及其功能特点[J].环境与健康杂志,2012,29(2):127130.
[9]Bauer B, Hartz AMS, Fricker G, et al. Pregnane X receptor upregulation of Pglycoptrotein expression and transport function at the bloodbrain barrier[J]. Mol Pharmacol, 2004, 66(3):413419.
[10]Malekshah OM, Lage H, Bahrami AR, et al. PXR and NFκB correlate with the inducing effects of IL1β and TNFα on ABCG2 expression in breast cancer cell lines[J]. European Journal of Pharmaceutical Sciences, 2012, 47(2):474480.
[11]Mosaffa F, Kalalinia F, Lage H, et al. Proinflammatory cytokines interleukin1β, interleukin6 and tumor necrosis factorα alter the expression of ABCG2 in cervix and gastric cancer cells[J]. Mol Cell Biochem, 2012, 363(12): 385393.
[12]Das A, Wallace IV GC, Holmes C, et al. Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors[J]. Neuroscience, 2012, 220:237246.
[13]Lzzo JG, Wu X, Wu TT, et al. Therapyinduced expression of NFkappa B portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation[J]. Dis Esophagus, 2009, 22(2): 127132.
[14]Lee SH, Kim H, Hwang JH, et al. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients[J]. Pathology International, 2012, 62(3):167175.